Adjuvant Bone-Targeted Therapies for Postmenopausal Breast Cancer

被引：5
作者：
Wilson, Caroline [1 ]
Coleman, Robert [1 ]
机构：
[1] Univ Sheffield, Weston Pk Hosp, Acad Unit Clin Oncol, Sheffield S10 2SJ, S Yorkshire, England
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 04期
关键词：
MULTICENTER;
D O I：
10.1001/jamaoncol.2015.5768
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：423 / 424
页数：2
相关论文
共 50 条
[41]   Metformin as an Adjuvant Treatment in Non-Diabetic Metastatic Breast Cancer [J].
Salah, Hager ;
Rabea, Hoda ;
Hassan, Ahmed ;
Elberry, Ahmed A. .
BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) :477-481
[42]   Is there a role for adjuvant pertuzumab in HER2-positive breast cancer? [J].
Mazzotta, Marco ;
Barba, Maddalena ;
Pizzuti, Laura ;
Vici, Patrizia .
TRANSLATIONAL CANCER RESEARCH, 2017, 6 :S281-S284
[43]   Proteomics as a Guide for Personalized Adjuvant Chemotherapy in Patients with Early Breast Cancer [J].
Lumachi, Franco ;
Chiara, Giordano B. ;
Foltran, Luisa ;
Basso, Stefano M. M. .
CANCER GENOMICS & PROTEOMICS, 2015, 12 (06) :385-390
[44]   Adjuvant abemaciclib for high-risk breast cancer: the story continues [J].
Spring, L. ;
Matikas, A. ;
Bardia, A. ;
Foukakis, T. .
ANNALS OF ONCOLOGY, 2021, 32 (12) :1457-1459
[45]   Effects of adjuvant treatment on cognitive function in women with early breast cancer [J].
Hedayati, Elham ;
Alinaghizadeh, Hassan ;
Schedin, Anna ;
Nyman, Hakan ;
Albertsson, Maria .
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2012, 16 (03) :315-322
[46]   Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature [J].
Meattini, Icro ;
Desideri, Isacco ;
Francolini, Giulio ;
Vannini, Agnese ;
Perna, Marco ;
Garlatti, Pietro ;
Grassi, Roberta ;
Livi, Lorenzo .
MEDICAL ONCOLOGY, 2017, 34 (05)
[47]   Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer [J].
Mustachio, Lisa Maria ;
Roszik, Jason .
PHARMACEUTICALS, 2020, 13 (11) :1-14
[48]   Neoadjuvant Treatment with HER2-Targeted Therapies in HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis [J].
Gunasekara, Agampodi Danushi M. ;
Anothaisintawee, Thunyarat ;
Youngkong, Sitaporn ;
Ha, Nguyen T. ;
McKay, Gareth J. ;
Attia, John ;
Thakkinstian, Ammarin .
CANCERS, 2022, 14 (03)
[49]   Tucatinib has Selective Activity in HER2-Positive Cancers and Significant Combined Activity with Approved and Novel Breast Cancer-Targeted Therapies [J].
O'Brien, Neil A. ;
Huang, Holly K. T. ;
McDermott, Martina S. J. ;
Madrid, Athena M. ;
Luo, Tong ;
Ayala, Raul ;
Issakhanian, Shawnt ;
Gong, Ke Wei ;
Lu, Ming ;
Zhang, Jun ;
Slamon, Dennis J. .
MOLECULAR CANCER THERAPEUTICS, 2022, 21 (05) :751-761
[50]   PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer [J].
Majewski, Ian J. ;
Nuciforo, Paolo ;
Mittempergher, Lorenza ;
Bosma, Astrid J. ;
Eidtmann, Holger ;
Holmes, Eileen ;
Sotiriou, Christos ;
Fumagalli, Debora ;
Jimenez, Jose ;
Aura, Claudia ;
Prudkin, Ludmila ;
Carmen Diaz-Delgado, Maria ;
de la Pena, Lorena ;
Loi, Sherene ;
Ellis, Catherine ;
Schultz, Nikolaus ;
de Azambuja, Evandro ;
Harbeck, Nadia ;
Piccart-Gebhart, Martine ;
Bernards, Rene ;
Baselga, Jose .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) :1334-1339
12345